Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Arosio

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Chemmedchem|April 11, 2012
Synthesis of Gd and (68)Ga complexes in conjugation with a conformationally optimized RGD sequence as potential MRI and PET tumor-imaging probesLeonardo Manzoni, Laura Belvisi, Daniela Arosio, et al.
Advanced Drug Delivery Reviews|December 23, 2021
HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer modelsGiulia Assoni, Valeria La Pietra, Rosangela Digilio, et al.
Bioconjugate Chemistry|July 10, 2012
Design, synthesis, and biological evaluation of novel cRGD-paclitaxel conjugates for integrin-assisted drug deliveryMichael Pilkington-Miksa, Daniela Arosio, Lucia Battistini, et al.
Scientific Reports|August 6, 2025
Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancerLorenzo Castagnoli, Francesco Bonì, Martina Bigliardi, et al.
Disease Models & Mechanisms|March 13, 2023
HuR modulation counteracts lipopolysaccharide response in murine macrophagesIsabelle Bonomo, Giulia Assoni, Valeria La Pietra, et al.
Archiv Der Pharmazie|December 19, 2023
A combined approach of structure-based virtual screening and NMR to interrupt the PD-1/PD-L1 axis: Biphenyl-benzimidazole containing compounds as novel PD-L1 inhibitorsGreta Donati, Monica Viviano, Vincenzo Maria D'Amore, et al.
Journal of Medicinal Chemistry|October 20, 2021
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 InhibitorsPasquale Russomanno, Giulia Assoni, Jussara Amato, et al.
Journal of Medicinal Chemistry|February 23, 2026
Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC ImmunotherapyFrancesco Merlino, Valentina Pagliara, Vincenzo Maria D'Amore, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Chemmedchem|April 11, 2012
Synthesis of Gd and (68)Ga complexes in conjugation with a conformationally optimized RGD sequence as potential MRI and PET tumor-imaging probesLeonardo Manzoni, Laura Belvisi, Daniela Arosio, et al.
Advanced Drug Delivery Reviews|December 23, 2021
HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer modelsGiulia Assoni, Valeria La Pietra, Rosangela Digilio, et al.
Bioconjugate Chemistry|July 10, 2012
Design, synthesis, and biological evaluation of novel cRGD-paclitaxel conjugates for integrin-assisted drug deliveryMichael Pilkington-Miksa, Daniela Arosio, Lucia Battistini, et al.
Scientific Reports|August 6, 2025
Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancerLorenzo Castagnoli, Francesco Bonì, Martina Bigliardi, et al.
Disease Models & Mechanisms|March 13, 2023
HuR modulation counteracts lipopolysaccharide response in murine macrophagesIsabelle Bonomo, Giulia Assoni, Valeria La Pietra, et al.
Archiv Der Pharmazie|December 19, 2023
A combined approach of structure-based virtual screening and NMR to interrupt the PD-1/PD-L1 axis: Biphenyl-benzimidazole containing compounds as novel PD-L1 inhibitorsGreta Donati, Monica Viviano, Vincenzo Maria D'Amore, et al.
Journal of Medicinal Chemistry|October 20, 2021
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 InhibitorsPasquale Russomanno, Giulia Assoni, Jussara Amato, et al.
Journal of Medicinal Chemistry|February 23, 2026
Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC ImmunotherapyFrancesco Merlino, Valentina Pagliara, Vincenzo Maria D'Amore, et al.
Pageof 6